https://www.selleckchem.com/pr....oducts/sar439859.htm
9 for each 1 μmol·L increase in S-HDLP , p0.05), at 1, 2, and 3 years from study entry in a combined cohort of all IPF subjects. Higher serum levels of S-HDLP are negatively correlated with the GAP index, as well as with lower observed mortality or lung transplantation in IPF subjects. These findings support the hypothesis that S-HDLP may modify mortality risk in patients with IPF. Higher serum levels of S-HDLPNMR are negatively correlated with the GAP index, as well as with lower observed mortality or lung transplantation in IPF
Like
Comment
Share
